SchizophreniaNCT07781007
Effectiveness of a Board Game Intervention on Cognitive and Functional Outcomes in Older Adults With Schizophrenia
A study testing Scaffolding-Based Board Game Intervention in people with Schizophrenia, run by Kaohsiung Kai-Suan Psychiatric Hospital at 1 site in Taiwan.
Trial summary
This study aims to evaluate the effects of a scaffolding-based board game intervention on cognitive and functional outcomes in older adults with schizophrenia living in psychiatric nursing homes. Participants will be assigned by clusters to either an intervention group or a control group. Read more about this study
- Who is it for?
- Ages 55 years and older
- Conditions the study is for
- Schizophrenia
- What is being tested?
- Scaffolding-Based Board Game Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 76 participants
- Where
- 1 siteTaiwan
- Study dates
- 9 Sep 2026to 2 Mar 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 55 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Aged 55 years or older.
- Diagnosed with schizophrenia by a board-certified psychiatrist.
- Has completed at least elementary school education.
- Has basic verbal communication ability and is able to understand and cooperate with study assessments and activities.
- Has sufficient vision and hearing, as assessed by care staff, to participate in board game instructions and activities.
- Is willing to participate in the study and provides written informed consent.
Who cannot join
- Has severe sensory impairment.
- Has severe visual or hearing impairment that interferes with participation in the study activities.
- Has experienced an acute exacerbation of psychiatric symptoms within the past 3 months.
- Is currently receiving other cognitive training or participating in another research study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Taiwan1 site
Daliao Psychiatric Nursing Home, Kaohsiung Municipal Kai-Syuan Psychiatric Hospital
Kaohsiung City
CHIU JUNG CHANG, +886-989-341-120, joce0989@gmail.com
About this study
Official title: Effectiveness of a Board Game Intervention on Cognitive and Functional Outcomes in Older Adults With Schizophrenia Living in Psychiatric Nursing Homes: A Cluster-Randomized Controlled Trial
This study aims to evaluate the effects of a scaffolding-based board game intervention on cognitive and functional outcomes in older adults with schizophrenia living in psychiatric nursing homes. Participants will be assigned by clusters to either an intervention group or a control group. The intervention group will receive a 12-week board game training program, while the control group will receive usual care. Cognitive and functional outcomes will be assessed before the intervention, immediately after the 12-week intervention, and three months after the intervention. The study will examine whether the board game intervention can improve cognitive and daily functioning in older adults with schizophrenia.
- Conditions
- Schizophrenia
- Being tested
- Scaffolding-Based Board Game Intervention
- Keywords
- Older Adults, Board Game Intervention, Cognitive Function, Psychiatric Nursing Home
- Medical subject headings
- Schizophrenia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Scaffolding-Based Board Game InterventionBehavioural
Participants will receive a scaffolding-based board game intervention once weekly for 12 weeks, with each session lasting approximately 60 minutes.
| Study group | Role | What they receive |
|---|---|---|
| Scaffolding-Based Board Game Intervention | Experimental | Not described Receives: Behavioral: Scaffolding-Based Board Game Intervention |
| Control Group | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Cognitive Function Assessed by MoCA-TW 7.1
The Montreal Cognitive Assessment-Taiwan Version 7.1 (MoCA-TW 7.1) is used to assess global cognitive function. The total score ranges from 0 to 30, with higher scores indicating better cognitive function.
Measured: Baseline, immediately after the 12-week intervention, and 3 months after completion of the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Aug 2026
- Study start9 Sep 2026 (estimated)
- Primary completion2 Dec 2026 (estimated)
- Study completion2 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SchizophreniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 76 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kaohsiung Kai-Suan Psychiatric Hospital
- Sponsor type
- Other government
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07781007
- Sponsor's protocol ID
- KSPH-2026-25
- Status last verified
- Sep 2026
- First submitted
- 19 Aug 2026
- Last updated
- 2 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of a Board Game Intervention on Cognitive and Functional Outcomes in Older Adults With Schizophrenia Living in Psychiatric Nursing Homes: A Cluster-Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07781007
- Acronym / sponsor ID
- KSPH-2026-25
- Conditions
- Schizophrenia
- Keywords
- Older Adults, Board Game Intervention, Cognitive Function, Psychiatric Nursing Home
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 76 participants (estimated)
- Lead sponsor
- Kaohsiung Kai-Suan Psychiatric HospitalOther government
- Study start
- 9 Sep 2026 (estimated)
- Primary completion
- 2 Dec 2026 (estimated)
- Study completion
- 2 Mar 2027 (estimated)
- First posted
- 24 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the effects of a scaffolding-based board game intervention on cognitive and functional outcomes in older adults with schizophrenia living in psychiatric nursing homes. Participants will be assigned by clusters to either an intervention group or a control group. The intervention group will receive a 12-week board game training program, while the control group will receive usual care. Cognitive and functional outcomes will be assessed before the intervention, immediately after the 12-week intervention, and three months after the intervention. The study will examine whether the board game intervention can improve cognitive and daily functioning in older adults with schizophrenia.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Scaffolding-Based Board Game Intervention | Experimental | Behavioral: Scaffolding-Based Board Game Intervention |
| Control Group | No intervention | – |
Who may qualify
- Ages
- 55 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Aged 55 years or older.
- Diagnosed with schizophrenia by a board-certified psychiatrist.
- Has completed at least elementary school education.
- Has basic verbal communication ability and is able to understand and cooperate with study assessments and activities.
- Has sufficient vision and hearing, as assessed by care staff, to participate in board game instructions and activities.
Key exclusion criteria (4 listed)
- Has severe sensory impairment.
- Has severe visual or hearing impairment that interferes with participation in the study activities.
- Has experienced an acute exacerbation of psychiatric symptoms within the past 3 months.
- Is currently receiving other cognitive training or participating in another research study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Scaffolding-Based Board Game InterventionParticipants will receive a scaffolding-based board game intervention once weekly for 12 weeks, with each session lasting approximately 60 minutes. | Behavioural | Scaffolding-Based Board Game Intervention |
Primary outcome
Cognitive Function Assessed by MoCA-TW 7.1
Time frame: Baseline, immediately after the 12-week intervention, and 3 months after completion of the intervention
The Montreal Cognitive Assessment-Taiwan Version 7.1 (MoCA-TW 7.1) is used to assess global cognitive function. The total score ranges from 0 to 30, with higher scores indicating better cognitive function.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Schizophrenia
RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia
Schizophrenia
Active, not recruitingPhase 2/3
Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
Suicidal Ideation, Major Depressive Disorder
RecruitingObservational study
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Schizophrenia
Not yet recruitingPhase 1
A Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable Schizophrenia
Schizophrenia
Not yet recruitingPhase 1
Phase I Trial of HHK101 in Patients With Schizophrenia
Schizophrenia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Scaffolding-Based Board Game Intervention in people with Schizophrenia, run by Kaohsiung Kai-Suan Psychiatric Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact CHIU JUNG CHANG (+886-989-341-120, joce0989@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cognitive Function Assessed by MoCA-TW 7.1 (time frame: Baseline, immediately after the 12-week intervention, and 3 months after completion of the intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026.